STOCK TITAN

Chemours (CC) Stock News

CC NYSE

Welcome to our dedicated page for Chemours news (Ticker: CC), a resource for investors and traders seeking the latest updates and insights on Chemours stock.

The Chemours Company reports developments for a global industrial and specialty chemicals business organized around Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. News commonly covers earnings releases, quarterly dividends, debt financing, and segment demand for products sold under brands including Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™.

Company updates also address refrigerants and thermal-management applications, TiO2 pigment pricing and volume trends, advanced fluoropolymers for semiconductor and electronics markets, and collaborations tied to high-density IT cooling and other specialty-chemistry uses.

Rhea-AI Summary

The Chemours Company (NYSE: CC) has suspended all business with Russian entities due to the ongoing military conflict and humanitarian crisis. CEO Mark Newman stated this decision aligns with the company’s values. Additionally, Chemours has donated $100,000 to the International Committee of the Red Cross to support humanitarian efforts in Ukraine. The company, which has a small office in Moscow, is prioritizing the safety of its employees and will continue to monitor the situation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.61%
Tags
none
-
Rhea-AI Summary

The Chemours Company (NYSE: CC) reported strong financial results for Q4 and FY 2021, with net sales of $6.3 billion and net income of $608 million, up 28% and 19% year-over-year, respectively. Adjusted EBITDA increased by 49% to $1.3 billion. The company announced a positive outlook for 2022, expecting Adjusted EBITDA between $1.3 billion and $1.425 billion, and projected Free Cash Flow exceeding $500 million. Chemours also repurchased $173 million in stock and reduced debt by $204 million throughout the year, highlighting its strong financial management and commitment to shareholder returns.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.42%
Tags
-
Rhea-AI Summary

The Chemours Company (NYSE: CC) has announced a quarterly cash dividend of $0.25 per share for Q1 2022, payable on March 15, 2022, to shareholders recorded by February 25, 2022. As a global leader in Titanium Technologies and Chemical Solutions, Chemours provides a wide range of products, including brands like Ti-Pure™ and Teflon™. With approximately 6,400 employees and operations in 120 countries, Chemours continues to deliver valuable solutions across various industries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.58%
Tags
dividends
Rhea-AI Summary

The Chemours Company (NYSE: CC) has appointed Guillaume Pepy to its board of directors, effective February 8, 2022. Pepy, a former CEO of SNCF Group, brings extensive experience in the European market and a strong background in customer relationship technologies. His leadership is expected to enhance Chemours' strategic direction as the company looks to maximize its business potential. This appointment is anticipated to contribute positively to Chemours' sustainable growth and regulatory insights.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.58%
Tags
management
-
Rhea-AI Summary

The Chemours Company (NYSE: CC) will release its fourth quarter 2021 financial results on February 10, 2022, after market close. A webcast conference call is scheduled for February 11, 2022, at 8:30 a.m. EST, accessible to the public through live webcast and teleconference. Chemours is a global leader in Titanium Technologies and other chemical solutions, serving approximately 3,300 customers worldwide. The company is headquartered in Wilmington, Delaware, and has about 6,500 employees across 30 manufacturing sites.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.47%
Tags
conferences earnings
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.47%
Tags
none
Rhea-AI Summary

The Chemours Company (NYSE: CC) has completed the sale of its Mining Solutions business to Draslovka Holding for $521 million. This strategic move aligns with Chemours' focus on sustainable growth in its key business sectors, aiming to enhance its balance sheet and long-term shareholder value. President and CEO Mark Newman emphasized that this transaction supports their ongoing transformational strategies and financial flexibility. Chemours is committed to disciplined capital allocation, continuing to build value across its three primary business areas.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.4%
Tags
none
-
Rhea-AI Summary

The Chemours Company (NYSE: CC) has launched Glyclean™ D, a broad-spectrum disinfectant registered with the U.S. EPA to deactivate SARS-CoV-2 and other pathogens. This product, comprising 70% glycolic acid, is biodegradable and less corrosive than traditional disinfectants like bleach. The launch reflects Chemours' commitment to innovation, aiming to meet cleaning needs across North America, Europe, the Middle East, Asia, and Latin America. The company operates approximately 30 manufacturing sites and serves about 3,300 customers globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.15%
Tags
none
-
Rhea-AI Summary

The Chemours Company (NYSE: CC) announced the opening of a new facility in El Dorado, Arkansas, to produce Opteon™ 1150, a low global warming potential hydrofluoroolefin (HFO). Production is set to commence before the January 2022 phase-down of CO2 equivalents mandated by the American Innovation and Manufacturing Act. Opteon™ 1150 enhances Chemours' portfolio of environmentally sustainable foam blowing agents, contributing to various industries including refrigeration and aerosol products. The company aims to meet increasing global demand for low GWP solutions while ensuring high performance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.48%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.55%
Tags
none

FAQ

What is the current stock price of Chemours (CC)?

The current stock price of Chemours (CC) is $21.52 as of June 11, 2026.

What is the market cap of Chemours (CC)?

The market cap of Chemours (CC) is approximately 3.1B.